Performs
An innovative start-up engaged in the development of new technologies for the treatment of skin inflammations.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | N/A | Early VC | |
| Total Funding | 000k | ||
| EUR | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
PerFormS Lab is an innovative startup that operates in the life sciences sector, specifically focusing on the development of health products based on advanced formulative technologies. The company is a spin-off from the Department of Life Sciences at the University of Modena and Reggio Emilia in Italy.
The primary goal of PerFormS Lab is to overcome biological barriers related to different methods of administration and to improve the bioavailability of active molecules, both natural and synthetic. Bioavailability refers to the extent and rate at which an administered drug is absorbed by the body's circulatory system, a critical factor in a drug's efficacy.
PerFormS Lab has developed a technology that enhances the pharmacological performance of an endogenous molecule with anti-inflammatory activity. This technology is designed to address the needs of patients suffering from acute or chronic skin inflammations, such as psoriasis.
The company's business model is rooted in the high-profitability biotech sector, which has been experiencing consistent annual growth. Founded by three university researchers with a strong background in pharmaceutical research, PerFormS Lab aims to develop the product derived from their technology as a new anti-inflammatory drug, positioning it as an alternative to cortisone.
In terms of revenue generation, the company likely aims to commercialize its innovative technology either through the sale of its anti-inflammatory drug or through licensing agreements with larger pharmaceutical companies.
Keywords: Life Sciences, Health Products, Advanced Formulative Technologies, Bioavailability, Pharmacological Performance, Endogenous Molecule, Anti-Inflammatory, Psoriasis, Biotech Sector, Pharmaceutical Research.